Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|4|4|305-314

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.4, 2015-07, pp. : 305-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A 2A -Receptor Agonist, in Healthy Male Volunteers

By Gordi Toufigh  

Clinical Pharmacokinetics, Vol. 45, Iss. 12, 2006-01 ,pp. : 1201-1212

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers

By Csajka C.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT 1A receptor agonist, using a behavioural model in rats

By Vis P.   Della Pasqua O.   Kruk M.   Martin D.   Mocaer E.   Danhof M.   Jochemsen R.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 233-243

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT 1A receptor agonist flesinoxan

By Zuideveld K.P.   van Gestel A.   Peletier L.A.   Van der Graaf P.H.   Danhof M.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 43-54

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats

By Cao Yanguang   Gao Wei   Jusko William  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1078-1086

Springer Publishing Company

Access to resources Recommend Favorite